Stock Summary | |
---|---|
Trade value(₹ in Lacs) 36.16 |
Face Value(₹)
10 |
MCap (₹ in Mn) 1,580.25 |
Price/Earning(TTM)
87.62 |
Dividend Yield(%) 0.0 |
Price/Sales(TTM)
8.31 |
TTM EPS(₹) 2.95 |
Price/Book(MRQ)
3.75 |
P/E Ratio 85.93 |
PAT Margin(%)
14.53 |
Book Value(₹) 68.94 |
ROCE(%)
20.37 |
Peer Companies | Previous Closing Price(₹) | 1D Chg(%) | Book Value(₹) | EPS (₹) | TTM / PE | 1 Year Return(%) | Market Cap (₹ Cr.) | Dividend Yield(%) |
---|---|---|---|---|---|---|---|---|
Neuland Laboratories | 11,674.45 | +2.45 | 1,182.3 | 202.2 | 60.88 | 56.09 | 15,793.59 | 0.10 |
Abbott India | 34,206.5 | +0.71 | 1,721.76 | 665.64 | 51.38 | 23.50 | 72,672.61 | 1.39 |
Mankind Pharma | 2,430.6 | +3.69 | 239.66 | 45.65 | 53.84 | 22.31 | 1,01,446.66 | 0.00 |
Sanofi Cons. Health | 5,139.45 | +1.61 | 118.26 | 73.08 | 71.77 | 12,078.18 | 1.05 | |
Glaxosmithkline Phar | 3,259.3 | +1.55 | 115.94 | 54.25 | 61.13 | 31.08 | 56,181.82 | 1.64 |
Astrazeneca Pharma I | 9,136.7 | +0.44 | 283.45 | 46.3 | 198.40 | 36.21 | 22,962.5 | 0.35 |
Natco Pharma | 986.75 | +3.78 | 312.42 | 103.31 | 9.73 | -15.06 | 17,999.65 | 0.60 |
Wockhardt | 1,657.15 | +2.22 | 115.78 | -0.74 | 0.00 | 92.34 | 27,482.81 | 0.00 |
Concord Biotech | 1,792.15 | +2.06 | 145.8 | 35.65 | 50.85 | 8.72 | 18,965.87 | 0.59 |
Hester Biosciences | 1,788.15 | +1.45 | 367.59 | 37.43 | 48.11 | -31.15 | 1,531.83 | 0.39 |